T. Lynch

A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.

M. Mihm, G. Dranoff, A. Sober, 1997, Human gene therapy.

Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma.

D. Neuberg, M. Mihm, F. Hodi, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction

D. Neuberg, M. Mihm, F. Hodi, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.

D. Neuberg, M. Mihm, A. Berns, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Continuous‐infusion cisplatin, 5‐fluorouracil, and bolus methotrexate in the treatment of advanced non‐small cell lung cancer

L. Kalish, T. Lynch, A. Elias, 1992, Cancer.

Cetuximab Monotherapy in Patients with Advanced Non-small Cell Lung Cancer After Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy

J. Neal, L. Sequist, P. Fidias, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

XL647—A Multitargeted Tyrosine Kinase Inhibitor: Results of a Phase II Study in Subjects with Non-small Cell Lung Cancer Who Have Progressed after Responding to Treatment with Either Gefitinib or Erlotinib

H. Wakelee, T. Lynch, V. Miller, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Association between self‐reported environmental tobacco smoke exposure and lung cancer: Modification by GSTP1 polymorphism

D. Neuberg, D. Christiani, J. Wain, 2003, International journal of cancer.

XL647—A Multitargeted Tyrosine Kinase Inhibitor: Results of a Phase II Study in Subjects with Non-small Cell Lung Cancer Who Have Progressed after Responding to Treatment with Either Gefitinib or Erlotinib

H. Wakelee, V. Miller, M. Pietanza, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.

D. Neuberg, M. Mihm, A. Berns, 1998, Proceedings of the National Academy of Sciences of the United States of America.

A phase I study of vaccination with lethally irradiated, autologous nonsmall cell lung carcinoma cells engineered by adenoviral mediated gene transfer to secrete human granulocyte-macrophage colony stimulating factor

M. Mihm, G. Dranoff, D. Sugarbaker, 2000 .